Effect of Biphasic Insulin Aspart 30 Combined with Metformin on Glycaemic Control in Obese People with Type 2 Diabetes

Authors

  • Belma Aščić - Buturović Endocrinology Clinic, Diabetes and Metabolic Diseases, University of Sarajevo Clinics Centre

DOI:

https://doi.org/10.17305/bjbms.2007.3023

Keywords:

Biphasic insulin aspart 30, metformin, diabetes mellitus type 2

Abstract

Combination therapy consisting of biphasic insulin aspart 30 bid with metformin provide better glycaemic control in obese patients with diabetes mellitus type 2. In our study, patients who were treated with 2550 mg of metformin, administered in three daily doses had poor glycaemic control. Three months after switching from metformin therapy to treatment with biphasic insulin aspart 30 + metformin twice a day, glycaemic control improved with significant reduction in hemoglobin HbA1c, fasting blood glucose and postprandial blood glucose levels.

Biphasic insulin aspart 30 in combination with metformin administered twice a day may be recommended as a starting insulin treatment in obese diabetic persons whose glycaemic control remained poor while on oral metformin therapy alone.

Effect of Biphasic Insulin Aspart 30 Combined with Metformin on Glycaemic Control in Obese People with Type 2 Diabetes

Downloads

Published

20-11-2007

Issue

Section

Translational and Clinical Research

Categories

How to Cite

1.
Effect of Biphasic Insulin Aspart 30 Combined with Metformin on Glycaemic Control in Obese People with Type 2 Diabetes. Biomol Biomed [Internet]. 2007 Nov. 20 [cited 2024 Mar. 19];7(4):335-8. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/3023